Melarsoprol
A medication used to treat African trypanosomiasis
Melarsoprol is a medication used for the treatment of African trypanosomiasis, also known as sleeping sickness. It is specifically used for the late stage of the disease, where the infection has reached the central nervous system. Melarsoprol is an organoarsenic compound and is known for its high toxicity, which limits its use.
Medical uses[edit | edit source]
Melarsoprol is primarily used to treat the second stage of Trypanosoma brucei infections, which are caused by the protozoan parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. These parasites are transmitted to humans through the bite of an infected tsetse fly. The second stage of the disease is characterized by the involvement of the central nervous system, leading to neurological symptoms such as confusion, poor coordination, and disturbances in sleep patterns.
Mechanism of action[edit | edit source]
Melarsoprol works by inhibiting the enzyme trypanothione reductase, which is essential for the survival of the trypanosome parasites. This enzyme is involved in the redox metabolism of the parasites, and its inhibition leads to the accumulation of toxic substances within the parasite, ultimately causing its death.
Side effects[edit | edit source]
The use of melarsoprol is associated with significant side effects due to its arsenic content. Common adverse effects include fever, vomiting, abdominal pain, and encephalopathy. The latter, known as reactive encephalopathy, can be fatal and occurs in approximately 5-10% of patients. Due to these severe side effects, melarsoprol is often considered a treatment of last resort.
History[edit | edit source]
Melarsoprol was developed in the 1940s and has been used extensively in the treatment of sleeping sickness. Despite its toxicity, it remains an important drug in regions where the disease is endemic, particularly in sub-Saharan Africa, due to the lack of alternative treatments for the late stage of the disease.
Alternatives[edit | edit source]
In recent years, alternative treatments such as eflornithine and nifurtimox have been developed and are used in combination therapies to reduce the reliance on melarsoprol. These alternatives are generally less toxic and have been shown to be effective in treating the second stage of sleeping sickness.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD